Tejo pratap Oleti

Dr. Tejo pratap Oleti

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Neonatology
Verified
Journal Article
Closed access
PDF file
SMSrinivas Murki
Srinivas Murki
JSJayesh Singh
Jayesh Singh
CKChiragkumar Khant
Chiragkumar Khant
SDSwarup Kumar Dash
Swarup Kumar Dash
TOTejo pratap Oleti
Tejo pratap Oleti
NKNandkishor S. Kabra
Nandkishor S. Kabra
Background: Nasal continuous positive airway pressure (nCPAP) is the standard noninvasive respiratory support for newborns with respiratory distress. Evidence for high-flow nasal cannula (HFNC) as an alternative mode of respiratory support is inconclusive. Objective: The aim of this work was to evaluate whether HFNC is not inferior to nCPAP in reducing the need for higher respiratory support in the first 72 h of life when applied as a noninvasive respiratory support mode for preterm neonates with respiratory distress. Methods: Preterm infants (gestation ≥28 weeks and birth weight ≥1,000 g) with respiratory distress were randomized to either HFNC or nCPAP in a non-inferiority trial. Failure of the support mode in the first 72 h after birth was the primary outcome. Infants failing HFNC were rescued either with nCPAP or mechanical ventilation, and those failing nCPAP received mechanical ventilation. Results: During the study period, 139 and 133 infants were randomized to the nCPAP and HFNC groups, respectively. The study was stopped after an interim analysis showed a significant difference (p < 0.001) in the primary outcome between the 2 groups. The treatment failure was significantly higher in the HFNC group (HFNC, n = 35, 26.3%, vs. CPAP, n = 11, 7.9%, risk difference 18.4 percentage points, 95% CI 9.7–27). Among the infants in the HFNC group who had treatment failure (n = 35), 32 were initially rescued with CPAP. The rate of mechanical ventilation in the first 3 and 7 days of life was similar between the 2 groups. Treatment failure was significantly higher in the HFNC group per protocol and also in the subgroups of infants with moderate (Silverman Anderson score, SAS ≤5) or severe respiratory distress (SAS score >5). Conclusions: When comparing HFNC to nCPAP as a primary noninvasive respiratory support in preterm infants with respiratory distress, HFNC is inferior to nCPAP in avoiding the need for a higher mode of respiratory support in the first 72 h of life.

31 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TBTanveer Bashir
Tanveer Bashir
SMSrinivas Murki
Srinivas Murki
SKSai Kiran
Sai Kiran
VRVenkat Kallem Reddy
Venkat Kallem Reddy
TOTejo pratap Oleti
Tejo pratap Oleti
With increasing use of nCPAP, the safety and comfort associated with nCPAP have come into the forefront. The reported incidence of nasal injuries associated with the use of nCPAP is 20% to 60%. A recent meta-analysis concluded that the use of nasal masks significantly decreases CPAP failure and the incidence of moderate to severe nasal injury and stress the need for a well powered RCT to confirm their findings. In this Open label, 3 arms, sequential, stratified randomized controlled trial, we evaluated the incidence and severity of nasal injury at removal of nCPAP when using two different nasal interfaces and in three groups (i.e. rotation group, mask continue group, prong continue group). Preterm infants with gestation ≤ 30 weeks and respiratory distress within the first 6 hours of birth and in need of CPAP were eligible for the study. Among the 175 newborns included in the study, incidence of nasal injury in mask continue group [n = 19/57 (33.3%)] was significantly less as compared to prong continue group [n = 55/60 (91.6%)] and rotation group [33/ 58 (56.9%), p value <0.0001]. Median maximum nasal injury score was significantly less in Mask continue group as compared to Prong continue group and Rotation group [Injury Score 0 (IQR 0–1) vs. Injury Score 3 (IQR 2–5) vs. Injury Score 1 (IQR 0–2), p value = <0.0001] respectively. The proportion of infants failing nCPAP was similar across the three groups. nCPAP with nasal masks significantly reduces nasal injury in comparison with nasal prongs or rotation of nasal prongs and nasal masks. However, the type of interface did not affect the nCPAP failure rates.

22 October 2018 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
TOTejo pratap Oleti
Tejo pratap Oleti
MSM. Jeeva Sankar
M. Jeeva Sankar
TAThukral Anu
Thukral Anu
VSV. Sreenivas
V. Sreenivas
AGArun Kumar Gupta
Arun Kumar Gupta
VPVinod K. Paul
Vinod K. Paul


21 January 2017 in Indian Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
HRHarish Rachuri
Harish Rachuri
TOTejo pratap Oleti
Tejo pratap Oleti
SMSrinivas Murki
Srinivas Murki
SSSreeram Subramanian
Sreeram Subramanian
JNJayalatha Nethagani
Jayalatha Nethagani

1 February 2018 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
APAakash Pandita
Aakash Pandita
SMSrinivas Murki
Srinivas Murki
TOTejo pratap Oleti
Tejo pratap Oleti
BTBaswaraj Tandur
Baswaraj Tandur
SKSai Kiran
Sai Kiran
APAmrut Prajapati
Amrut Prajapati
Meconium staining of amniotic fluid (MSAF) occurs in 10% to 15% of all deliveries. Infants born with MSAF are 100-fold more likely to develop substantial respiratory distress than infants born through clear amniotic fluid. About 1.5% to 8.0% of infants born through MSAF develop meconium aspiration syndrome (MAS).1,2 Approximately 30% to 50% of infants with MAS have severe MAS, defined as the need for mechanical ventilation (MV).3-5 The optimum methods of providing respiratory support to infants with MAS are not known.6,7 Though ventilation is a life-saving measure, ventilation in itself results in ventilation-induced lung injury, and the need for MV translates into prolonged hospital stays, increased burden on the health care system, and increased treatment costs.8,9 Nasal continuous positive airway pressure (NCPAP) as a primary respiratory therapy in MAS has not been studied extensively. When NCPAP is applied in newborns with MAS, it may resolve atelectasis by expanding partially obstructed small airways and stabilizing the collapsing terminal airways to enhance oxygen exchange. Nasal continuous positive airway pressure in MAS may be used as a substitute or as a bridge to MV. Therefore, we conducted this multicenter randomized clinical trial to evaluate the efficacy of NCPAP in comparison with standard care (5-10 L/min hood oxygen) in reducing the subsequent need for MV in newborns with MAS.